These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38243899)

  • 1. A Novel Leu-Enkephalin Prodrug Produces Pain-Relieving and Antidepressant Effects.
    Hohenwarter L; Puil E; Rouhollahi E; Bohrmann L; Lu S; Saatchi K; Häfeli UO; Barr A; Böttger R; Viswanadham KKD; Li SD
    Mol Pharm; 2024 Feb; 21(2):688-703. PubMed ID: 38243899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Effective and Safe Enkephalin Analog for Antinociception.
    Viswanadham KKD; Böttger R; Hohenwarter L; Nguyen A; Rouhollahi E; Smith A; Tsai YH; Chang YY; Ortiz CL; Yang LW; Jimenez L; Li S; Hur C; Li SD
    Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34206631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal administration of delta receptor agonists in the urethane anesthetized rat provokes an increase in arterial pressure via a non-opioid mechanism.
    Rochford J; Henry JL
    Brain Res; 1990 Apr; 512(2):259-68. PubMed ID: 2162234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal ERK2 activation through δ2-opioid receptors contributes to nociceptive behavior induced by intrathecal injection of leucine-enkephalin.
    Komatsu T; Katsuyama S; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Peptides; 2014 Apr; 54():131-9. PubMed ID: 24480726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Chemokine CCL4 (MIP-1β) Evokes Antinociceptive Effects in Mice: a Role for CD4
    García-Domínguez M; Lastra A; Folgueras AR; Cernuda-Cernuda R; Fernández-García MT; Hidalgo A; Menéndez L; Baamonde A
    Mol Neurobiol; 2019 Mar; 56(3):1578-1595. PubMed ID: 29907903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DSLET (D-ser2-leu5-enkephalin-Thr6) produces analgesia on the hot plate by mechanisms largely different from DAGO and morphine-like opioids.
    Belknap JK; Laursen SE
    Life Sci; 1987 Jul; 41(4):391-5. PubMed ID: 3298912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal morphine-3-glucuronide-induced nociceptive behavior via Delta-2 opioid receptors in the spinal cord.
    Komatsu T; Katsuyama S; Nagase H; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Pharmacol Biochem Behav; 2016 Jan; 140():68-74. PubMed ID: 26476133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid and non-opioid receptor-mediated immunoregulatory role of leucine-enkephalin in teleost Channa punctatus.
    Singh R; Rai U
    Fish Shellfish Immunol; 2010; 28(5-6):872-8. PubMed ID: 20153438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supraspinal delta 2 opioid agonist analgesia in Swiss-Webster mice involves spinal GABAA receptors.
    Rady JJ; Fujimoto JM
    Pharmacol Biochem Behav; 1996 Jun; 54(2):363-9. PubMed ID: 8743596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic administration of the bifunctional opioid/neuropeptide FF receptors agonist BN-9 produced peripheral antinociception in preclinical mouse models of pain.
    Li N; Han ZL; Xu B; Zhang MN; Zhang T; Shi XR; Zhao WD; Guo YY; Zhang QQ; Fang Q
    Eur J Pharmacol; 2018 Oct; 837():53-63. PubMed ID: 30172787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo properties of KNT-127, a novel δ opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice.
    Nozaki C; Nagase H; Nemoto T; Matifas A; Kieffer BL; Gaveriaux-Ruff C
    Br J Pharmacol; 2014 Dec; 171(23):5376-86. PubMed ID: 25048778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RB101-mediated protection of endogenous opioids: potential therapeutic utility?
    Jutkiewicz EM
    CNS Drug Rev; 2007; 13(2):192-205. PubMed ID: 17627672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of humoral immune response by central administration of leucine-enkephalin: effects of mu, delta and kappa opioid receptor antagonists.
    Radulović J; Mancev Z; Stanojević S; Vasiljević T; Kovacević-Jovanović V; Pesić G
    J Neuroimmunol; 1996 Apr; 65(2):155-61. PubMed ID: 8964897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone.
    Le Guen S; Mas Nieto M; Canestrelli C; Chen H; Fournié-Zaluski MC; Cupo A; Maldonado R; Roques BP; Noble F
    Pain; 2003 Jul; 104(1-2):139-48. PubMed ID: 12855323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible lipidization for the oral delivery of leu-enkephalin.
    Wang J; Hogenkamp DJ; Tran M; Li WY; Yoshimura RF; Johnstone TB; Shen WC; Gee KW
    J Drug Target; 2006 Apr; 14(3):127-36. PubMed ID: 16753826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased content of immunoreactive Leu-enkephalin and alteration of delta-opioid receptor in hearts of spontaneously hypertensive rats.
    Dumont M; Lemaire S
    Neurosci Lett; 1988 Nov; 94(1-2):114-8. PubMed ID: 2853850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery.
    Kumar M; Pandey RS; Patra KC; Jain SK; Soni ML; Dangi JS; Madan J
    Int J Biol Macromol; 2013 Oct; 61():189-95. PubMed ID: 23831532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
    Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB; Welch SP
    Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of humoral immune responses in the rat by centrally applied Met-Enk and opioid receptor antagonists: functional interactions of brain OP1, OP2 and OP3 receptors.
    Dimitrijević M; Stanojević S; Kovacević-Jovanović V; Miletić T; Vujić-Redzić V; Radulović J
    Immunopharmacology; 2000 Sep; 49(3):255-62. PubMed ID: 10996023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.